International Journal of Clinical Practice

Cover image for Vol. 66 Issue 8

August 2012

Volume 66, Issue 8

Pages 725–821

  1. Editorials

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
  2. Perspective

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. You have free access to this content
  3. Endocrinology

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. You have free access to this content
  4. Oncology

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer (pages 748–752)

      A. Pennycuick, T. Simpson, D. Crawley, R. Lal, G. Santis, P. Cane, K. Tobal and J. Spicer

      Version of Record online: 16 JUL 2012 | DOI: 10.1111/j.1742-1241.2012.02961.x

    2. You have full text access to this OnlineOpen article
      Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin-based chemotherapy (pages 753–757)

      F. Longo, G. Mansueto, V. Lapadula, L. Stumbo, G. Del Bene, D. Adua, L. De Filippis, E. Bonizzoni and S. Quadrini

      Version of Record online: 2 JUL 2012 | DOI: 10.1111/j.1742-1241.2012.02969.x

  5. Gastroenterology

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. You have free access to this content
  6. Renal

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. Risk factors influencing the outcome of peptic ulcer bleeding in end stage renal diseases after initial endoscopic haemostasis (pages 774–781)

      S.-C. Lin, K.-L. Wu, K.-W. Chiu, C.-T. Lee, Y.-C. Chiu, Y.-P. Chou, M.-L. Hu, W.-C. Tai, S.-S. Chiou, T.-H. Hu, C.-S. Changchien and S.-K. Chuah

      Version of Record online: 1 JUN 2012 | DOI: 10.1111/j.1742-1241.2012.02974.x

  7. Cardiovascular

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. You have free access to this content
      Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6–24 weeks (pages 800–812)

      P. P. Toth, D. Morrone, W. S. Weintraub, M. E. Hanson, R. S. Lowe, J. Lin, A. K. Shah and A. M. Tershakovec

      Version of Record online: 16 JUL 2012 | DOI: 10.1111/j.1742-1241.2012.02964.x

  8. Urology

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter
    1. You have free access to this content
  9. Letter

    1. Top of page
    2. Editorials
    3. Perspective
    4. Endocrinology
    5. Oncology
    6. Gastroenterology
    7. Renal
    8. Cardiovascular
    9. Urology
    10. Letter

SEARCH

SEARCH BY CITATION